{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:14:20Z","timestamp":1768410860172,"version":"3.49.0"},"reference-count":91,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,12,4]],"date-time":"2006-12-04T00:00:00Z","timestamp":1165190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>Recombinant activated factor VII (rFVIIa) was originally developed for the treatment of bleeding in patients with haemophilia A or B and inhibitors. Over the past ten years, it has been successfully used to prevent or control bleeding in several other nonhaemophilic bleeding conditions. Among the newer \u2018off\u2010label\u2019 clinical applications of rFVIIa, there is increasing evidence of its effectiveness in treating obstetric and gynaecological bleeding unresponsive to conventional therapy. The existing literature on the use of rFVIIa in obstetrics and gynaecology is summarised in this review. Although supported by few and uncontrolled studies, on the whole, the published data suggest a potential role of rFVIIa in the management of obstetric and gynaecological intractable bleeding. However, further evidence is needed to improve the assessment of its optimal dose, effectiveness and safety in such conditions.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2006.01156.x","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T16:04:39Z","timestamp":1165334679000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage"],"prefix":"10.1111","volume":"114","author":[{"given":"M","family":"Franchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199803000-00002"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(98)00026-5"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200004001-00005"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200011000-00015"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-16890"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00017.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1160\/TH05-01-0032","article-title":"Recombinant factor VIIa. An update on its clinical use","volume":"93","author":"Franchini M","year":"2005","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000135405.29702.3c"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04052.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2003.12.003"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH04-03-0163","article-title":"The use of rFVIIa in non\u2010haemophilia bleeding conditions in paediatrics","volume":"92","author":"Mathew P","year":"2004","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2001.29507"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057301"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2223"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.curobgyn.2003.12.004"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200109000-00002"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)90000-2"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4463256.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.24.14477"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.12.4581"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00225.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01015.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116691"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00181.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.175"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01227.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/beog.1999.0060"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000180909.31293.cf"},{"key":"e_1_2_7_30_2","first-page":"69","article-title":"Factors associated with postpartum hemorrhage with vaginal birth","volume":"77","author":"Combs CA","year":"1991","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2003.028"},{"key":"e_1_2_7_32_2","first-page":"77","article-title":"Factors associated with hemorrhage in cesarean deliveries","volume":"77","author":"Combs CA","year":"1991","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02505330"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053381882"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003249"},{"key":"e_1_2_7_36_2","first-page":"292","article-title":"Hereditary factor VII deficiency in pregnancy: cesarean treatment with recombinant FVIIa","volume":"4","author":"Haya S","year":"1998","journal-title":"Haemophilia"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199806000-00013"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00424.x"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02878.x"},{"key":"e_1_2_7_40_2","first-page":"80b","article-title":"Treatment of a post partum bleeding complication with recombinant factor VIIa","volume":"98","author":"Brueckner S","year":"2001","journal-title":"Blood"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/88.5.734"},{"key":"e_1_2_7_42_2","first-page":"21","article-title":"Efficacy of recombinant activated factor VII (rFVIIa, NovoSeven\u00ae) in prenatal medicine","volume":"8","author":"Breborowicz GH","year":"2002","journal-title":"Arch Perinat Med"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000064699"},{"key":"e_1_2_7_44_2","first-page":"230","article-title":"Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy","volume":"73","author":"Sobieszczyk S","year":"2002","journal-title":"Ginekol Pol"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)01953-1"},{"key":"e_1_2_7_46_2","first-page":"155","article-title":"Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after cesarean section\u2014a case report","volume":"26","author":"Sokolic V","year":"2002","journal-title":"Coll Antropol"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200306000-00008"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-003-0482-2"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00009.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TA.0000135142.80368.65"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00058.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2004.00501.x"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000127943.68645.96"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2004.147"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei094"},{"key":"e_1_2_7_56_2","first-page":"512","article-title":"Use of recombinant factor VIIa for massive postpartum haemorrhage: case series and review of literature","volume":"55","author":"Shamsi TS","year":"2005","journal-title":"J Pak Med Assoc"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2005.00596.x"},{"key":"e_1_2_7_58_2","first-page":"144","article-title":"Successful treatment of severe post\u2010partum bleeding after caesarean section using recombinant activated factor VII","volume":"70","author":"Holub Z","year":"2005","journal-title":"Ceska Gynekol"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000180268.85925.78"},{"key":"e_1_2_7_60_2","first-page":"259","article-title":"Recombinant factor VIIa for severe bleeding during cesarean section for quadruplet pregnancy. Case report","volume":"37","author":"Nowacka E","year":"2005","journal-title":"Anest Intens Ter"},{"key":"e_1_2_7_61_2","first-page":"81","article-title":"Use of recombinant activated factor VII in a case of severe postpartum haemorrhage","volume":"58","author":"Verre M","year":"2006","journal-title":"Minerva Ginecol"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000220249.42907.ff"},{"key":"e_1_2_7_63_2","first-page":"1","article-title":"Management recommendations for postpartum hemorrhage","volume":"10","author":"Sobieszczyk S","year":"2004","journal-title":"Arch Perinat Med"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5026"},{"issue":"12","key":"e_1_2_7_65_2","first-page":"21","article-title":"Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia","volume":"38","author":"Poon MC","year":"2001","journal-title":"Semin Hematol"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2000.00007.x"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20390"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04162.x"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650169"},{"key":"e_1_2_7_70_2","first-page":"112","volume-title":"Anniversary Volume for Robert Tilden Frank; By His Colleagues, Collaborators, Associates, and Friends","author":"Rosenthal N","year":"1937"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602960000600206"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20702"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80049-8"},{"key":"e_1_2_7_74_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1470-0328(03)01935-9","article-title":"Register of acquired factor VIII inhibitors (RIIA). Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice","volume":"110","author":"Baudo F","year":"2003","journal-title":"BJOG"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<1::AID-AJH1>3.0.CO;2-T"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1651666"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-200012000-00003"},{"key":"e_1_2_7_78_2","first-page":"3877","article-title":"Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor","volume":"100","author":"Baudo F","year":"2002","journal-title":"Blood"},{"key":"e_1_2_7_79_2","first-page":"405","article-title":"Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII\u2010inhibitor hemophilia","volume":"125","author":"Meili EO","year":"1995","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01128.x"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2001.00529.x"},{"key":"e_1_2_7_82_2","first-page":"85b","article-title":"Recombinant factor VIIa for intractable surgical bleeding","volume":"96","author":"Laffan MA","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200011020-00006"},{"key":"e_1_2_7_84_2","first-page":"309","article-title":"Successful use of activated recombinant factor FVIIa in the management of intra abdominal haemorrhage after cytoreductive surgery for advanced carcinoma of the ovary\u2014a case report","volume":"52","author":"Panek G","year":"2002","journal-title":"Nowotwory"},{"key":"e_1_2_7_85_2","first-page":"325","article-title":"Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII","volume":"23","author":"Sajdak S","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200306000-00007"},{"key":"e_1_2_7_87_2","doi-asserted-by":"crossref","unstructured":"WeilbachC ScheinischenD JuettnerB SchuerholzT PlepenbrockS.Excessive blood loss after abdominal hysterectomy\u2014use of recombinant factor VIIa.Anasthesiol Intensivmed Notf Med Schmerzther2004;39:672\u20135.","DOI":"10.1055\/s-2004-825982"},{"key":"e_1_2_7_88_2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1055\/s-0037-1614304","article-title":"Recombinant factor VIIa in a patient with Glanzmann\u2019s thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment","volume":"92","author":"Coppola A","year":"2004","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_89_2","first-page":"180","article-title":"Thrombasthenia of Glanzmann. Vaginal hysterectomy treated with recombinant factor VIIa","volume":"17","author":"Mairos JS","year":"2004","journal-title":"Acta Med Port"},{"key":"e_1_2_7_90_2","doi-asserted-by":"publisher","DOI":"10.1089\/gyn.2005.21.13"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000224854.88366.05"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.3.293"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2006.01156.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2006.01156.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:24:50Z","timestamp":1697037890000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2006.01156.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,4]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1111\/j.1471-0528.2006.01156.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2006.01156.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,4]]},"assertion":[{"value":"2006-12-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}